What if the study that scared an entire generation of women away from hormone replacement therapy was fundamentally flawed — and the fallout lasted twenty years?

Rick and Greg sit down with Caitlin Robinson, NP, to trace the full arc of female HRT: from the optimism of the 1960s through the 2002 Women's Health Initiative study that brought it to a hard stop, to the slow, ongoing rehabilitation of the science.

Caitlin breaks down the three core problems with the WHI — wrong patients (mostly women over 60, a decade past menopause), wrong medications (synthetic hormones instead of bioidenticals), and a misreading of risk that got amplified by media coverage into something close to panic. She explains what bioidentical hormones actually are, why women's hormonal balance is more complex than a single testosterone number, and what the current consensus looks like for timing, candidacy, and individualized care.

They also get honest about the downstream cost: women who lost years of quality of life, a generation of older women with fragile bones and metabolic disease, and primary care providers still practicing off guidelines written in the shadow of a flawed study.

This is Part 1 of a multi-episode series on women's hormonal health.

For informational purposes only — not medical advice. Talk to your provider.